Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patupilone in Hormone Refractory Prostate Cancer
NCT00407251Phase 2Completed
- Sponsor
- BC Cancer
- Start
- Feb 2007
- Primary completion
- Jun 2010
- Modality
- Covalent Small Molecules, RNA-Targeting Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patupilone in prostate cancer (PCa), sponsored by BC Cancer. Started Feb 2007; status: completed.
02
Drugs
patupilone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00407251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407251.